261 related articles for article (PubMed ID: 27475276)
1. Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy.
Loimu V; Seppälä T; Kapanen M; Tuomikoski L; Nurmi H; Mäkitie A; Tenhunen M; Saarilahti K
Radiother Oncol; 2017 Feb; 122(2):178-184. PubMed ID: 27475276
[TBL] [Abstract][Full Text] [Related]
2. Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation.
Shi D; Qian JJ; Fan GH; Shen JK; Tian Y; Xu L
BMC Oral Health; 2019 Dec; 19(1):288. PubMed ID: 31864328
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
Fan WJ; Teng F; Luo YR; Yu W; Zhang Q; Lu YP; Ma L
Strahlenther Onkol; 2020 Jun; 196(6):530-541. PubMed ID: 32025803
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy.
Dirix P; De Keyzer F; Vandecaveye V; Stroobants S; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1365-71. PubMed ID: 18355977
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Salivary Gland Function Using Diffusion-Weighted Magnetic Resonance Imaging for Follow-Up of Radiation-Induced Xerostomia.
Zhang Y; Ou D; Gu Y; He X; Peng W
Korean J Radiol; 2018; 19(4):758-766. PubMed ID: 29962882
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted MR imaging of salivary glands with gustatory stimulation: comparison before and after radiotherapy.
Zhang Y; Ou D; Gu Y; He X; Peng W; Mao J; Yue L; Shen X
Acta Radiol; 2013 Oct; 54(8):928-33. PubMed ID: 23821773
[TBL] [Abstract][Full Text] [Related]
7. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
[TBL] [Abstract][Full Text] [Related]
8. Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era.
Lee SW; Kang KW; Wu HG
Head Neck; 2016 Apr; 38 Suppl 1():E1746-55. PubMed ID: 26875880
[TBL] [Abstract][Full Text] [Related]
9. Early Changes in Apparent Diffusion Coefficient for Salivary Glands during Radiotherapy for Nasopharyngeal Carcinoma Associated with Xerostomia.
Zhang Q; Wei YM; Qi YG; Li BS
Korean J Radiol; 2018; 19(2):328-333. PubMed ID: 29520191
[TBL] [Abstract][Full Text] [Related]
10. Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands.
Kapanen M; Collan J; Saarilahti K; Heikkonen J; Kairemo K; Tenhunen M
Radiother Oncol; 2009 Oct; 93(1):109-14. PubMed ID: 19435641
[TBL] [Abstract][Full Text] [Related]
11. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
[TBL] [Abstract][Full Text] [Related]
12. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
13. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
14. Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer.
Tenhunen M; Collan J; Kouri M; Kangasmäki A; Heikkonen J; Kairemo K; Mäkitie A; Joensuu H; Saarilahti K
Radiother Oncol; 2008 May; 87(2):260-7. PubMed ID: 18329118
[TBL] [Abstract][Full Text] [Related]
15. Mathematical evaluation of post-radiotherapy salivary gland function using salivary gland scintigraphy.
Itonaga T; Tokuuye K; Mikami R; Shimizu A; Sato H; Yoshimura M; Tsukahara K; Saito K
Br J Radiol; 2022 Feb; 95(1130):20210718. PubMed ID: 34928174
[TBL] [Abstract][Full Text] [Related]
16. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
[TBL] [Abstract][Full Text] [Related]
17. [Study on DWMRI in evaluating the influence of intensity modulated radiotherapy on salivary gland function of nasopharyngeal carcinoma patients].
Li Y; Zhao C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 50(9):754-9. PubMed ID: 26696349
[TBL] [Abstract][Full Text] [Related]
18. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
[TBL] [Abstract][Full Text] [Related]
19. The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy.
Rudat V; Münter M; Rades D; Grötz KA; Bajrovic A; Haberkorn U; Brenner W; Debus J
Radiother Oncol; 2008 Oct; 89(1):71-80. PubMed ID: 18707782
[TBL] [Abstract][Full Text] [Related]
20. [Quantitative salivary gland scintigraphy in head and neck cancer patients following radiotherapy].
Jiménez-Heffernan A; Gómez-Millán J; Sánchez De Mora E; Delgado Moreno J; Delgado Gil MM; Salgado C; Contreras Puertas P; Bermúdez Morales MC; López J; Paz Expósito J
Rev Esp Med Nucl; 2010; 29(4):165-71. PubMed ID: 20462671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
